课题基金 / 基金详情

Physiological and functional effects of beta-cell-specific inactivation of the PGE2 receptor EP3

Physiological and functional effects of beta-cell-specific inactivation of the PGE2 receptor EP3
PGE2 受体 EP3 β 细胞特异性失活的生理和功能影响
批准号:
10248348
负责人:
Ashley A Christensen
金额:
$1.15万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-09-01 至 2021-12-31

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
项目总结/文摘
英文摘要
Project summary/Abstract Type 2 diabetes is a major health concern in the United States. It occurs when individuals fail to compensate for an increased demand for insulin from the pancreatic β cells. The prostaglandin E receptor EP3 (encoded by Ptger3), which responds to prostaglandin E2 (PGE2), has been shown to inhibit insulin secretion. EP3 is upregulated in diabetic individuals and with age. Data from our lab has demonstrated that ex vivo pharmacological inhibition of EP3 increases β cell mass and survival. The role of EP3 specifically in the β cell has not been examined. I propose using a β-cell-specific EP3 KO mouse model to determine the effect of EP3 inactivation in the context of high fat diet. In addition, FoxM1 is a transcription factor necessary for β cell proliferation. FoxM1 levels decrease with age while EP3 levels increase. In this proposal, I outline experiments to elucidate what role, if any, FoxM1 has in regulating Ptger3 expression.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金